dc.contributor.author |
Araya, Ricardo |
|
dc.contributor.author |
Rossi-Menezes, Paulo |
|
dc.contributor.author |
García-Claro, Heloísa |
|
dc.contributor.author |
Brandt, Lena R. |
|
dc.contributor.author |
Daley, Kate L. |
|
dc.contributor.author |
Quayle, Julieta |
|
dc.contributor.author |
Diez-Canseco Montero, Francisco |
|
dc.contributor.author |
Peters, Tim J. |
|
dc.contributor.author |
Vera-Cruz, Daniela |
|
dc.contributor.author |
Toyama, Mauricio |
|
dc.contributor.author |
Aschar, Suzana |
|
dc.contributor.author |
Hidalgo Padilla, Liliana Milagros |
|
dc.contributor.author |
Martins, Hellen |
|
dc.contributor.author |
Cavero, Victoria |
|
dc.contributor.author |
Rocha, Thais |
|
dc.contributor.author |
Scotton, George |
|
dc.contributor.author |
de Almeida Lopes, Ivan F. |
|
dc.contributor.author |
Begale, Mark |
|
dc.contributor.author |
Mohr, David C. |
|
dc.contributor.author |
Miranda, J. Jaime |
|
dc.date.accessioned |
2021-06-08T15:46:13Z |
|
dc.date.available |
2021-06-08T15:46:13Z |
|
dc.date.issued |
2021 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/9485 |
|
dc.description.abstract |
IMPORTANCE: Depression is a leading contributor to disease burden globally. Digital mental health interventions can address the treatment gap in low- and middle-income countries, but the effectiveness in these countries is unknown. OBJECTIVE: To investigate the effectiveness of a digital intervention in reducing depressive symptoms among people with diabetes and/or hypertension. DESIGN, SETTING, AND PARTICIPANTS: Participants with clinically significant depressive symptoms (Patient Health Questionnaire-9 [PHQ-9] score ≥10) who were being treated for hypertension and/or diabetes were enrolled in a cluster randomized clinical trial (RCT) at 20 sites in São Paulo, Brazil (N=880; from September 2016 to September 2017; final follow-up, April 2018), and in an individual-level RCT at 7 sites in Lima, Peru (N=432; from January 2017 to September 2017; final follow-up, March 2018). INTERVENTIONS: An 18-session, low-intensity, digital intervention was delivered over 6 weeks via a provided smartphone, based on behavioral activation principles, and supported by nurse assistants (n = 440 participants in 10 clusters in São Paulo; n = 217 participants in Lima) vs enhanced usual care (n = 440 participants in 10 clusters in São Paulo; n = 215 participants in Lima). MAIN OUTCOMES AND MEASURES: The primary outcome was a reduction of at least 50% from baseline in PHQ-9 scores (range, 0-27; higher score indicates more severe depression) at 3 months. Secondary outcomes included a reduction of at least 50% from baseline PHQ-9 scores at 6 months. RESULTS: Among 880 patients cluster randomized in Brazil (mean age, 56.0 years; 761 [86.5%] women) and 432 patients individually randomized in Peru (mean age, 59.7 years; 352 [81.5%] women), 807 (91.7%) in Brazil and 426 (98.6%) in Peru completed at least 1 follow-up assessment. The proportion of participants in São Paulo with a reduction in PHQ-9 score of at least 50% at 3-month follow-up was 40.7% (159/391 participants) in the digital intervention group vs 28.6% (114/399 participants) in the enhanced usual care group (difference, 12.1 percentage points [95% CI, 5.5 to 18.7]; adjusted odds ratio [OR], 1.6 [95% CI, 1.2 to 2.2]; P = .001). In Lima, the proportion of participants with a reduction in PHQ-9 score of at least 50% at 3-month follow-up was 52.7% (108/205 participants) in the digital intervention group vs 34.1% (70/205 participants) in the enhanced usual care group (difference, 18.6 percentage points [95% CI, 9.1 to 28.0]; adjusted OR, 2.1 [95% CI, 1.4 to 3.2]; P < .001). At 6-month follow-up, differences across groups were no longer statistically significant. CONCLUSIONS AND RELEVANCE: In 2 RCTs of patients with hypertension or diabetes and depressive symptoms in Brazil and Peru, a digital intervention delivered over a 6-week period significantly improved depressive symptoms at 3 months when compared with enhanced usual care. However, the magnitude of the effect was small in the trial from Brazil and the effects were not sustained at 6 months |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
American Medical Association |
|
dc.relation.ispartofseries |
JAMA |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Female |
en_US |
dc.subject |
Humans |
en_US |
dc.subject |
Male |
en_US |
dc.subject |
Middle Aged |
en_US |
dc.subject |
Peru |
en_US |
dc.subject |
Adult |
en_US |
dc.subject |
Brazil |
en_US |
dc.subject |
*Mobile Applications |
en_US |
dc.subject |
*Telemedicine |
en_US |
dc.subject |
Behavior Therapy/*methods |
en_US |
dc.subject |
Depression/complications/nursing/*therapy |
en_US |
dc.subject |
Diabetes Mellitus/*psychology |
en_US |
dc.subject |
Hypertension/*psychology |
en_US |
dc.subject |
Odds Ratio |
en_US |
dc.subject |
Smartphone |
en_US |
dc.title |
Effect of a Digital Intervention on Depressive Symptoms in Patients With Comorbid Hypertension or Diabetes in Brazil and Peru: Two Randomized Clinical Trials |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1001/jama.2021.4348 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.00 |
|
dc.relation.issn |
1538-3598 |
|